Oncology Voice Network (OVN) Podcast Podcast Por Oncology Voice Network arte de portada

Oncology Voice Network (OVN) Podcast

Oncology Voice Network (OVN) Podcast

De: Oncology Voice Network
Escúchala gratis

Oncology Voice Network (OVN) Podcast brings the real-world voices of oncology drug development to life. Hosted by Dr. Kirk Shepard and Dr. Ramin Farhood, the series features candid conversations with leaders and innovators across the oncology ecosystem. Each episode explores real-world experiences, lessons learned, bold ideas, challenges, and best practices and solutions from pharmaceutical executives, academic researchers, patients, patient advocates, and innovation partners—connecting the voices that drive oncology drug development forward. At its core, the show reflects the mission of the Oncology Voice Network: breaking silos, amplifying voices, and fostering cross-functional collaboration across all disciplines to reshape oncology drug development. Whether you’re in pharmaceuticals, biotech, healthcare, or advocacy, this podcast offers insights and connections to help drive progress across the field.2026 Oncology Voice Network Ciencia Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Why Relationships Define Medical Affairs Leadership
    Apr 14 2026

    Ever wonder why some medical affairs professionals consistently rise to the top?

    In this episode of Oncology Voice Network podcast, host Dr. Kirk Shepard talks with Tom Caravela, whose three decades in life sciences and hundreds of placements have revealed what really moves careers forward in medical affairs—especially in the world of oncology.

    Explore how the Medical Science Liaison role has evolved from generalist to subject matter expert, why your network is as crucial as your scientific expertise, and the career advice you should never follow. Tom Caravela shares how developing intentional relationships, effective cross-functional communication, and a growth mindset can make the difference whether you’re leading, building teams, or charting the next step in your field medical career.

    Packed with actionable takeaways, book and podcast recommendations, and candid stories of both failures and breakthroughs, this is your roadmap for thriving in today’s high-stakes medical affairs landscape.

    Want to know how to stand out and make a lasting impact? Tune in to the voices shaping the future of oncology.

    Follow Us

    • Facebook @OncologyVoiceNetwork
    • LinkedIn @OncologyVoiceNetwork
    • X @OncologyVoiceNetwork

    Presented by Oncology Voice Network
    www.oncologyvoicenetwork.com


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    24 m
  • Breakthroughs in Oncology Drug Development with Dr. Roy Baynes
    Mar 31 2026

    How do world-changing cancer treatments go from concept to reality?

    In this episode of the Oncology Voice Network Podcast, host Dr. Kirk Shepard welcomes Dr. Roy Baynes, the Chief Medical Officer of ICON Therapeutics and the architect behind the clinical strategy for Keytruda (pembrolizumab), one of the most transformative cancer therapies of our time.

    Listen as Dr. Baynes shares his personal journey from academia to industry, his leadership and collaboration philosophy, and the critical decisions that accelerated one drug to impact millions. He reveals how adaptive trials, bold partnerships, clear strategy, and relentless patient focus set new standards—not only for science, but for access and equity in cancer care.

    From lessons learned at Amgen, Gilead, and Merck, to navigating regulatory relationships and cross-functional teamwork, this episode is a masterclass in what it takes to drive rapid oncology innovation. Dr. Baynes also looks ahead to the future, sharing his optimism for breakthroughs, actionable insights for teams, and why patient-centered purpose should lead every step.

    Tune in and discover how strategy, leadership, and heart unite to change lives in oncology—listen now.

    Follow Us

    • Facebook @OncologyVoiceNetwork
    • LinkedIn @OncologyVoiceNetwork
    • X @OncologyVoiceNetwork

    Presented by Oncology Voice Network
    www.oncologyvoicenetwork.com


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    28 m
  • The Power of Commercial Leadership in Oncology
    Mar 17 2026

    What does it mean to be the true “voice of commercial” in oncology, and why does it matter more than ever?

    In this episode of Oncology Voice Network Podcast, join Dr. Kirk Shepard as he welcomes Daniel Switzer, Head of U.S. Oncology at Daiichi Sankyo, for a revealing look inside the commercial engine that drives cancer innovation from the lab all the way to the patient. With two decades of leading launches, transformations, and cross-functional teams, Daniel Switzer shares his most pivotal moments, from high-stakes encounters with patients to standing ovations at ASCO Congress.

    Discover why commercial is about so much more than sales, how ethical responsibility and clear alignment can truly change outcomes, and what happens when teams get it wrong. Daniel Switzer discusses breaking down silos, building bridges with R&D, and the necessity of early, unified collaboration in launching life-changing therapies. Plus, hear why the Oncology Voice Network and industry-wide learning are the next frontiers in elevating patient care.

    Whether you're in pharma, research, or just passionate about innovation, this episode will reframe what commercial leadership means in today’s oncology world.

    Tune in now and get inspired to bridge the gaps that matter most.

    Follow Us

    • Facebook @OncologyVoiceNetwork
    • LinkedIn @OncologyVoiceNetwork
    • X @OncologyVoiceNetwork

    Presented by Oncology Voice Network
    www.oncologyvoicenetwork.com


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    31 m
Todavía no hay opiniones